Scientists seek to discover new production routes when manufacturing limits arise. Returning to stirred-bed vessels is an innovative way of going forward by returning to the roots while bringing in the necessary chemical and engineering adaptions. The first DNA...
It is an exciting time to manufacture peptides and oligonucleotides, molecules used in countless medicines undergoing rapid change and growth. We’ve looked at some of the driving forces behind this development and why it benefits chemical manufacturers of these...
A strategic alliance is an agreement between two businesses that have opted to pool their resources (such as manufacturing capabilities, knowledge, technologies, or risks) in order to work on a particular project that will benefit both parties and provide value. In...
Reach your drug manufacturing goals by working with CDMOs (contract development and manufacturing organisations). In this blog, we explore exactly what CDMOs are and how they can help your business to overcome challenges in the long and complex process of developing...
The biopharmaceutical industry has seen a significant increase in interest in oligonucleotide-based drugs over the past five years. These drugs were originally used to treat rare diseases but are now being developed to target more common diseases and larger patient...
The therapeutic usage of oligonucleotide-based drugs is growing. Moving from rare diseases to chronic indications, the market demand for oligonucleotide therapeutics keeps increasing and is coupled by the emergence of new challenges related to scalability,...
Cookie Settings We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operations of the website, as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. Please note that based on your settings, it is possible that not all functionalities of the website will be available. You can find further information in our Privacy Policy
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.